Obesity Pharmacology has 208 eligible papers in the latest 30-day evidence window, up 58% from the prior window, with representative work spanning Ephedrae Herba and Ephedrine on Nervous System: A Comprehensive Review of Pharmacology and Neurotoxicity; A cost-effectiveness analysis of herbal medicine for overweight and obese children; and Pharmacological Screening Model and Phytoconstituent for AntiObesity Activity: Comprehensive Overview.
Obesity Pharmacology shows 208 eligible recent papers and 208 commentary-ready papers in the current 30-day window, compared with 132 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers.
Obesity Pharmacology recorded 208 eligible papers in the latest 30-day window, compared with 132 in the prior 30-day window, making the current snapshot up 58% from the prior window.
208 recent vs 132 prior eligible papersPharmacology and Obesity Treatment contributes 208 eligible recent papers, including 208 papers with abstracts available for commentary.
208 papers in the leading clusterThe representative set includes Ephedrae Herba and Ephedrine on Nervous System: A Comprehensive Review of Pharmacology and Neurotoxicity; A cost-effectiveness analysis of herbal medicine for overweight and obese children; Pharmacological Screening Model and Phytoconstituent for AntiObesity Activity: Comprehensive Overview; Survodutide Once Weekly for the Treatment of Adults with Obesity; and Virtual screening of human pancreatic lipase inhibitors using an integrated transfer learning and molecular dynamics simulation. These papers anchor the page's claims and keep the brief tied to visible evidence.
8 representative papersPharmacology and Obesity Treatment accounts for 208 eligible recent papers, including 208 commentary-ready papers in this evidence window.
208 recent eligible papersThe selected papers cover Ephedrae Herba and Ephedrine on Nervous System: A Comprehensive Review of Pharmacology and Neurotoxicity; A cost-effectiveness analysis of herbal medicine for overweight and obese children; Pharmacological Screening Model and Phytoconstituent for AntiObesity Activity: Comprehensive Overview; and Survodutide Once Weekly for the Treatment of Adults with Obesity.
8 representative papersA recent paper from The American Journal of Chinese Medicine in the Pharmacology and Obesity Treatment evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Medicine in the Pharmacology and Obesity Treatment evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from International Journal of Drug Delivery Technology in the Pharmacology and Obesity Treatment evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from New England Journal of Medicine in the Pharmacology and Obesity Treatment evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Bioinformation in the Pharmacology and Obesity Treatment evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from European Cardiology Review in the Pharmacology and Obesity Treatment evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Journal of Ethnic Foods in the Pharmacology and Obesity Treatment evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Diabetes in the Pharmacology and Obesity Treatment evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.